DK0422975T3 - Alfa-Glucosidase-inhibitorer - Google Patents

Alfa-Glucosidase-inhibitorer

Info

Publication number
DK0422975T3
DK0422975T3 DK90402613.5T DK90402613T DK0422975T3 DK 0422975 T3 DK0422975 T3 DK 0422975T3 DK 90402613 T DK90402613 T DK 90402613T DK 0422975 T3 DK0422975 T3 DK 0422975T3
Authority
DK
Denmark
Prior art keywords
alpha
glucosidase inhibitors
glucosidase
inhibitors
Prior art date
Application number
DK90402613.5T
Other languages
Danish (da)
English (en)
Inventor
Charles Danzin
Jean-Bernard Ducep
Original Assignee
Merrell Dow Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharma filed Critical Merrell Dow Pharma
Application granted granted Critical
Publication of DK0422975T3 publication Critical patent/DK0422975T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/044—Pyrrole radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/26—Acyclic or carbocyclic radicals, substituted by hetero rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Molecular Biology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Emergency Medicine (AREA)
  • Virology (AREA)
  • Endocrinology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • AIDS & HIV (AREA)
  • Child & Adolescent Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK90402613.5T 1989-10-10 1990-09-21 Alfa-Glucosidase-inhibitorer DK0422975T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP89402794A EP0422307A1 (en) 1989-10-10 1989-10-10 Novel alpha-glucosidase inhibitors

Publications (1)

Publication Number Publication Date
DK0422975T3 true DK0422975T3 (da) 1994-08-22

Family

ID=8202997

Family Applications (1)

Application Number Title Priority Date Filing Date
DK90402613.5T DK0422975T3 (da) 1989-10-10 1990-09-21 Alfa-Glucosidase-inhibitorer

Country Status (21)

Country Link
US (1) US5097023A (no)
EP (2) EP0422307A1 (no)
JP (1) JP3032266B2 (no)
KR (1) KR0183012B1 (no)
CN (1) CN1029974C (no)
AR (1) AR246745A1 (no)
AT (1) ATE109153T1 (no)
AU (1) AU632855B2 (no)
CA (1) CA2027276C (no)
DE (1) DE69011033T2 (no)
DK (1) DK0422975T3 (no)
ES (1) ES2060980T3 (no)
FI (1) FI101796B1 (no)
HU (1) HU209724B (no)
IE (1) IE64079B1 (no)
IL (1) IL95928A (no)
NO (1) NO174203C (no)
NZ (1) NZ235578A (no)
PT (1) PT95547B (no)
TW (1) TW225539B (no)
ZA (1) ZA907936B (no)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5504078A (en) * 1990-06-08 1996-04-02 Merrell Dow Pharmaceuticals Inc. α-glucosidase inhibitors
US5268364A (en) * 1991-12-12 1993-12-07 The Biomembrane Institute Method for inhibiting selectin-dependent adhesion of leukocytes and platelets by O-glycosylation modification
US5843921A (en) 1994-03-15 1998-12-01 Childrens Hospital Of Los Angeles Therapeutic food composition and method to diminish blood sugar fluctuations
US5605893A (en) * 1994-03-15 1997-02-25 Children's Hospital Of Los Angeles Method of using a therapeutic food composition to diminish blood sugar fluctuations in diabetic patients
JP3580900B2 (ja) * 1995-04-20 2004-10-27 ホクレン農業協同組合連合会 α−グルコシダーゼ阻害剤を含む糖を主体とする組成物を有効成分とする食品及び飼料
US5929037A (en) * 1995-06-07 1999-07-27 Alberta Research Council Modified α-D-Glcρ-(1-2)-α-D-Glcρ-(1-3)-α-D-Glcρ-analogues
IL124109A (en) * 1995-09-08 2001-10-31 Novo Nordisk As Pharmaceutical composition of 2-alkylpyrrolidines for use in the manufacture of medicaments for the treatment of diabetes
WO1998009981A1 (en) * 1996-09-09 1998-03-12 Wisconsin Alumni Research Foundation Human salivary proteins and fragments thereof having alpha-glucosidase inhibitory activity
US6534487B1 (en) 1999-08-03 2003-03-18 Childrens Hospital Los Angeles Methods for suppressing appetite and enhancing exercise and recovery
CA2397578A1 (en) * 1999-12-21 2001-06-28 Ajinomoto Co., Inc. A partial ester of a nitrogenous carboxylic acid with cellulose and a process for preparing the same
JP4486792B2 (ja) * 2003-06-12 2010-06-23 学校法人近畿大学 環状オニウム化合物およびグルコシダーゼ阻害剤

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO154918C (no) * 1977-08-27 1987-01-14 Bayer Ag Analogifremgangsmaate til fremstilling av terapeutisk aktive derivater av 3,4,5-trihydroksypiperidin.

Also Published As

Publication number Publication date
ES2060980T3 (es) 1994-12-01
AU632855B2 (en) 1993-01-14
ZA907936B (en) 1991-08-28
JP3032266B2 (ja) 2000-04-10
DE69011033D1 (de) 1994-09-01
CN1050879A (zh) 1991-04-24
PT95547A (pt) 1991-08-14
NO904372L (no) 1991-04-11
HU906389D0 (en) 1991-04-29
FI904965A0 (fi) 1990-10-09
IL95928A0 (en) 1991-07-18
TW225539B (no) 1994-06-21
AR246745A1 (es) 1994-09-30
US5097023A (en) 1992-03-17
NO174203C (no) 1994-04-06
PT95547B (pt) 1998-02-27
DE69011033T2 (de) 1994-11-17
EP0422975B1 (en) 1994-07-27
EP0422307A1 (en) 1991-04-17
FI101796B (fi) 1998-08-31
IE903613A1 (en) 1991-04-24
AU6375690A (en) 1991-04-18
CN1029974C (zh) 1995-10-11
NZ235578A (en) 1992-10-28
KR0183012B1 (ko) 1999-04-01
NO904372D0 (no) 1990-10-09
IE64079B1 (en) 1995-07-12
HUT55402A (en) 1991-05-28
CA2027276C (en) 2000-05-16
ATE109153T1 (de) 1994-08-15
EP0422975A1 (en) 1991-04-17
HU209724B (en) 1994-10-28
KR910007951A (ko) 1991-05-30
FI101796B1 (fi) 1998-08-31
NO174203B (no) 1993-12-20
JPH03127797A (ja) 1991-05-30
CA2027276A1 (en) 1991-04-11
IL95928A (en) 1994-08-26

Similar Documents

Publication Publication Date Title
ATE129716T1 (de) Alpha-glukosidase-inhibitoren.
DE3864608D1 (de) Hmg-coa-reduktasehemmer.
FI904101A0 (fi) 17b-acyl-4-aza-5a-androst-1-en-3-on- som 5a-reduktasinhibitorer.
DK317287D0 (da) Reduktase-inhibitorer
BR8907457A (pt) Inibidores de interleucina-1
DK0409676T3 (da) Acetylcholinesterase-inhibitorer
DK0422975T3 (da) Alfa-Glucosidase-inhibitorer
IT9020623A0 (it) procedimento
FI94711B (fi) Hevosenkenkä
DK69489A (da) Aspartattranscarbamylase-inhibitorer
HU901879D0 (en) New alpha-glucosidase inhibitors
IT9020793A0 (it) inibizione
ATA149789A (de) Schienenrad
NO921066D0 (no) Gangbro
MX9203697A (es) Nuevos inhibidores de acetilcolinesterase.
BR8906629A (pt) Transgui ii
DK658489A (da) Proteaseinhibitorer
SE8902790D0 (sv) Insats till mattornister
IT218982Z2 (it) Custodia per densatore
NO176501C (no) Hestesko
KR910004429U (ko) 블 럭
BR6900847U (pt) Tele-alarme
ATA152989A (de) Skistock
SE8900619D0 (sv) Skaerklinga
ATA293489A (de) Schibob